|
|
|
Insider
Information: |
Smith Cynthia |
Relationship: |
Director |
City: |
Coppell |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
185,923 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$438,502 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
185,923 |
|
|
Total
Value |
$438,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Zs Pharma, Inc. |
ZSPH |
Chief Commercial Officer |
2015-12-17 |
0 |
2015-12-08 |
0 |
Premium* |
|
Akebia Therapeutics, Inc. |
AKBA |
|
2024-06-06 |
125,233 |
2019-06-06 |
0 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-06-03 |
0 |
Premium* |
|
Spero Therapeutics Inc |
SPRO |
|
2024-05-29 |
55,000 |
2022-09-15 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-06-13 |
5,690 |
2023-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ZSPH |
Zs Pharma, Inc. |
Chief Commercial Officer |
|
2015-12-08 |
4 |
OE |
$10.92 |
$100,011 |
D/D |
9,155 |
9,155 |
0 |
- |
|
ZSPH |
Zs Pharma, Inc. |
Chief Commercial Officer |
|
2015-12-17 |
4 |
D |
$90.00 |
$1,133,820 |
D/D |
(12,598) |
0 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
13,700 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2019-11-20 |
4 |
B |
$3.52 |
$52,800 |
D/D |
15,000 |
28,700 |
0.01 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
42,400 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2020-06-08 |
4 |
AS |
$12.10 |
$55,261 |
D/D |
(4,567) |
37,833 |
0 |
% |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
51,533 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2021-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
3,333 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2021-12-28 |
4 |
D |
$38.25 |
$127,487 |
D/D |
(3,333) |
0 |
0 |
- |
|
SPRO |
Spero Therapeutics Inc |
Director |
|
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2023-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
95,233 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-08-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,302 |
2,302 |
0 |
- |
|
SPRO |
Spero Therapeutics Inc |
|
|
2023-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
35,000 |
0 |
- |
|
SPRO |
Spero Therapeutics Inc |
|
|
2024-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
55,000 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
125,233 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2024-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,388 |
5,690 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|